Now an independent consultant and non-profit founder, Kirsten previously was on the leadership team of Pfizer Inc’s $30 billion global innovative pharmaceutical business. She led Strategy and Business Evaluation for Rare Disease, Oncology, Inflammation & Immunology and Primary Care. Kirsten also led Pfizer’s Global Policy team. She founded and is the Secretary of the Preparedness and Treatment Equity Coalition. She is also a visiting scholar with the American Enterprise Institute, an Aspen Institute Health Fellow and a senior advisor to DLA Piper.
Kirsten is a board member for Ramapo for Children and Aequitas Health, worked in Ethiopia with the International Trachoma initiative and climbed Mt. Kilimanjaro with other healthcare leaders to raise $1.6 million for the Fred Hutchinson Cancer Center.